+1 (202) 780-3397
Telehealth literacy as a social determinant of health: A novel screening tool to support vulnerable patient equity
15th World Congress on DEMENTIA AND ALZHEIMER'S DISEASE
November 21, 2022 | Webinar
Monica Gillie
Ochsner Health, USA
Posters & Accepted Abstracts : J Clin Psychiatry Cog Psychol
Abstract:
The objective of this review is to propose the Telehealth Literacy Screening Tool (TLST) for use in older adults and support the future inclusion of telehealth literacy as an important Social Determinant of Health (SDOH). Initially a fourweek outreach was performed that targeted older adults and low-health literate patients at the MedVantage Clinic (MVC) within Ochsner Health (OH) to identify common barriers to patient engagement with the OH Epic MyChart telehealth platform. Themes from those barriers directed a meta-synthetic review of the methods and ethical considerations of current, validated technological and telehealth literacy screening tools. Based on the barriers identified during our MVC patient outreach, review of telehealth literacy screening research, and evaluation of the MyChart platform and the technological resources required for its use; we developed a multidimensional questionnaire for telehealth literacy screening of older adults. The TLST is designed to identify patients in need of additional interventions for successful connection to telehealth services. This is an important step towards addressing the ethical obligation to decrease disparities in telehealth literacy for older populations and identifying telehealth literacy as a SDOH. References 1. Triana, Austin J et al. “Technology Literacy as a Barrier to Telehealth During COVID-19.” Telemedicine journal and e-health: the official journal of the American Telemedicine Association vol. 26,9 (2020): 1118-1119. doi:10.1089/tmj.2020.0155 2. Lam, Kenneth et al. “Assessing Telemedicine Unreadiness Among Older Adults in the United States During the COVID-19 Pandemic.” JAMA internal medicine vol. 180,10 (2020): 1389- 1391. doi:10.1001/jamainternmed.2020.2671 3. Daly, Timothy et al. “The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols.” Theoretical medicine and bioethics vol. 41,5-6 (2020): 223-237. doi:10.1007/s11017-020-09536-7
PDF HTML